Uremic Toxicity and Bone in CKD
Suguru Yamamoto(Niigata University), Masafumi Fukagawa(FIND)
Cited by 62
Related Papers
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
|European Heart Journal|2018|323
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update
|Annals of Internal Medicine|2018|316
CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis.
|American Journal of Roentgenology|1997|296
Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
|Journal of the American College of Cardiology|2012|205